Shuttle Pharmaceuticals Holdings, Inc. Common Stock
SHPH Real Time Price USDRecent trades of SHPH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SHPH's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Selective histone deacetylase inhibitors for the treatment of human disease Sep. 03, 2024
-
Patent Title: Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation May. 23, 2023
-
Patent Title: Selective histone deacetylase inhibitors for the treatment of human disease Feb. 21, 2023
-
Patent Title: Selective histone deacetylase inhibitors for the treatment of human disease Aug. 09, 2022
-
Patent Title: Selective histone deacetylase inhibitors for the treatment of human disease Jun. 15, 2021
-
Patent Title: Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof Aug. 18, 2020
-
Patent Title: Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof Aug. 04, 2020
-
Patent Title: Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof Nov. 07, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of SHPH in WallStreetBets Daily Discussion
Recent insights relating to SHPH
Recent picks made for SHPH stock on CNBC
ETFs with the largest estimated holdings in SHPH
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SHPH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.